Prot #CSTI571A2406: An open label, multi-center imatinib roll-over protocol for patients who have completed a previous Novartis-sponsored imatinib study and are judged by the investigator to benefit from continued imatinib treatment

  • Frankfurt, Olga (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date12/1/128/31/23

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CSTI571A2406)